The short version of glucagon receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-23 and is reviewed periodically as new material appears.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
=== In film and television === Sanders appeared in a cameo role in the 1988 comedy-drama film Sweet Hearts Dance, playing a man who distributes candy to young trick-or-treaters. In 1999, he acted in the film My X-Girlfriend's Wedding Reception, playing Rabbi Manny Shevitz. In this role, he mourned the Brooklyn Dodgers' move to Los Angeles, reflecting Sanders's own upbringing in Brooklyn. On February 6, 2016, he was a guest star alongside Larry David (who is a sixth cousin once removed of Sanders) on Saturday Night Live, playing a Polish immigrant on a steamship that was sinking near the Statue of Liberty. In the DC Extended Universe film Birds of Prey (and the Fantabulous Emancipation of One Harley Quinn), one of the reasons Roman Sionis wants Harley Quinn dead is that she "voted for Bernie".
[NH4]2CO3 + CaSO4 → [NH4]2SO4 + CaCO3 Ammonium sulfate occurs naturally as the rare mineral mascagnite in volcanic fumaroles and due to coal fires on some dumps. Ammonium sulfate is a byproduct in the production of methyl methacrylate (CH2=C(CH3)COOCH3).
=== Provincial government === Yasir Naqvi, the Attorney General of Ontario, and Eric Hoskins, the province's Minister of Health and Long-Term Care, jointly announced on the day of Wettlaufer's sentencing that the provincial government would commission a public inquiry into her case. The full details of the inquiry were not given in the announcement, as the government had yet to determine the scope or an individual to lead the inquiry, with Naqvi and Hoskins instead saying that the inquiry would "get the answers we need to help ensure a tragedy such as this does not happen again." The delay in establishing the inquiry was criticized by members of the opposition Progressive Conservative and New Democratic parties toward the end of July 2017, as no progress had seemingly been made since the announcement and the Legislative Assembly had risen for its summer recess. The Public Inquiry into the Safety and Security of Residents in the Long-Term Care Homes System was formally established by the provincial government on August 1, 2017. Justice Eileen Gillese of the Court of Appeal for Ontario was appointed commissioner of the inquiry. The inquiry was to include interviews with victims' families and public consultations in the community as it investigated the circumstances surrounding the deaths of Wettlaufer's victims and gaps in legislative or policy frameworks that allowed her to continue working as a nurse. The inquiry's lead counsel stated that "anyone from Wettlaufer to Premier Kathleen Wynne" may be called to testify before the inquiry based on the evidence that is uncovered.
== Origin == Whenever muscles and joints are moved this also exerts mechanical strain on related fascia. The general assumption in sports science had therefore been that muscle strength exercises as well as cardiovascular training would be sufficient for an optimal training of the associate fibrous connective tissues. However, recent ultrasound-based research revealed that the mechanical threshold for a training effect on tendinous tissues tends to be significantly higher than for muscle fibers. This insight happened roughly during the same time in which the field of fascia research attracted major attention by showing that fascial tissues are much more than passive transmitters of muscular tension (years 2007 – 2010). Both influences together triggered an increasing attention in sports science towards the question whether and how fascial tissues can be specifically stimulated with active exercises. Researchers who contributed to the initial scientific investigation of this direction include Robert Schleip, Jan Wilke, Michael Kjaer and Adamantios Arampatzis.
Sources: en.wikipedia.org
===== ICONIC-LEAD ===== The ICONIC-LEAD study is a phase III, randomized, double-blind, placebo-controlled trial evaluating icotrokinra versus placebo in patients with moderate to severe plaque psoriasis. The study met its co-primary endpoints, with 74% of patients achieving clear or almost clear skin (IGA 0/1) at week 24.
Currently the railway has been under-grounded: the avenue will be enlarged and have same architecture style of southern Corso Inghilterra in downtown, becoming one of the major avenues of Turin. The northern part of the district was part of the former industrial district of Turin, recently reconverted to a park called Parco Dora. Mainly, in San Donato the portion reconverted was the one occupied by the plant of Michelin (west of Via Livorno) and Fiat ironwork plants (on the East). Differently for other portions of Parco Dora, this part has been totally reconverted to park without letting any evidence of the industrial area except for the cooling tower which stands along Corso Umbria and became a symbol of the park. Works are completed in the western area, where Corso Mortara has been closed to traffic and moved just a bit northern and covered by an artificial tunnel. It is possible to access the southern shore of the River Dora. South of the park, an interesting architecture of different levels is hosting a new shopping mall called Centro Commerciale Parco Dora. East of Via Livorno, works are still partially in progress, with the River Dora still to be uncovered by a big slab, on which the Fiat plants used to stand). West of Via Livorno, the Environment Park is a research centre for renewable energy.
Early research in the 19th and 20th centuries on osmosis and diffusion provided the foundation for understanding the passive movement of molecules across cell membranes. In 1855, the physiologist Adolf Fick was the first to define osmosis and simple diffusion as the tendency for solutes to move from a region of higher concentration to a lower concentration, also very well-known as Fick's Laws of Diffusion. Through the work of Charles Overton in the 1890s, the concept that the biological membrane is semipermeable became important to understanding the regulation of substances in and out of the cells. The discovery of facilitated diffusion by Wittenberg and Scholander suggested that proteins in the cell membrane aid in the transport of molecules. In the 1960s - 1970s, studies on the transport of glucose and other nutrients highlighted the specificity and selectivity of membrane transport proteins. Technological advancements in biochemistry helped isolate and characterize these proteins from cell membranes. Genetic studies on bacteria and yeast identified genes responsible for encoding transporters. This led to the discovery of glucose transporters (GLUT proteins), with GLUT1 being the first to be characterized. Identification of gene families encoding various transporters, such as solute carrier (SLC) families, also advanced knowledge on uniporters and its functions. Newer research is focusing on techniques using recombinant DNA technology, electrophysiology and advanced imaging to understand uniporter functions.
Agilent ChemStation is a software package to control Agilent liquid chromatography, gas chromatography, and ultraviolet-visible spectroscopy systems such as the 1050, 1100 and 1200 Series HPLC system and the 8453 and 8454 single-beam diode array detector spectrophotometers. It is an evolution of the Hewlett-Packard ChemStation System. Two versions are available: one ("online") in connection with the modules of the HPLC chain is designed to control instruments and run experiments, and the other ("offline"), without a connection with the HPLC chain, is designed to analyze data. ChemStation is structured around a number of registers. Two of the more important registers are CHROMREG and CHROMRES, the chromatographic data registers. Other special registers exist for the UV-vis implementation of the software. ChemStation has a command line interpreter and can run macros. Those macros are files grouping a set of commands. These files possess a .mac extension. ChemStation can import analysis lists and export result files in XML by adding new lines to the ChemStation.ini configuration file. This is a feature to implement the connection with a Laboratory information management system (LIMS).
Peppermint (Mentha × piperita) is a hybrid species of mint, a cross between watermint and spearmint. Indigenous to Europe and the Middle East, the plant is now widely spread and cultivated in many regions of the world. It is occasionally found in the wild with its parent species. Although the genus Mentha comprises more than 25 species, peppermint is the most widely used variant. While Western peppermint is derived from Mentha × piperita, Chinese peppermint, or bohe, is derived from the fresh leaves of M. haplocalyx. M. × piperita and M. haplocalyx are both recognised as plant sources of menthol and menthone, and are among the oldest herbs used for both culinary and medicinal products.
Sources: en.wikipedia.org
During the Islamic Golden Age under the Abbasid Caliphate, prominent Muslim physicians preserved, systematized and developed ancient medical knowledge from across the Eurasian continent. They synthesized concepts from classical antiquity (see: Ancient Greece, Ancient Rome), Persia, Ayurveda, and China. This work laid the foundations for later advances in medieval European medicine as European physicians came into contact with Islamic authors through the Renaissance of the 12th century. Rhazes (c. 865–925), or Muhammad ibn Zakariya al-Razi, included writings about diabetes in the more than 230 books he produced in his lifetime. Avicenna (980–1037), or Ibn Sina, was a court physician to the caliphs of Baghdad and a key figure in medicine who compiled an exhaustive medical encyclopedia titled The Canon of Medicine. His account detailed the clinical features of diabetes, and termed the disease albulab ("water wheel") and zalkh el kuliah ("diarrhea of the kidneys"). He documented "the abnormal appetite and the collapse of sexual functions" and the sweet taste of diabetic urine, and further differentiated diabetes associated with emaciation from other causes of polyuria. He also elaborated on diabetic gangrene and treated diabetes using a mixture of lupine, trigonella (fenugreek), and zedoary seed. It has been noted that references to diabetes expanded in the medical texts of this period. Eknoyan and Nagy (2005) speculate that this indicates the increasing prevalence of the disease.
Piggott; Fermented Beverage Production, Kluwer Academic/Plenum Publishers, 2003, ISBN 0-306-47706-8 McFarland, Ben; World's Best Beers, Sterling Publishing, 2009, ISBN 978-1-4027-6694-7 Oliver, Garrett (ed); The Oxford Companion to Beer, Oxford University Press, 2011 Priest, Fergus G.; Handbook of Brewing, CRC Press, 2006, ISBN 0-8247-2657-X Rabin, Dan and Forget, Carl; The Dictionary of Beer and Brewing, Fitzroy Dearborn/Taylor & Francis, 1998 ISBN 978-1-57958-078-0 Stevens, Roger, et al.; Brewing: Science and Practice, Woodhead Publishing, 2004, ISBN 0-8493-2547-1 Unger, Richard W.; Beer in the Middle Ages and the Renaissance, University of Pennsylvania Press, 2004, ISBN 0-8122-3795-1
On March 5, 1946, Winston Churchill, while at Westminster College in Fulton, Missouri, gave his speech "The Sinews of Peace", declaring that an "iron curtain" had descended across Europe. From the standpoint of the Soviets, the speech was an incitement for the West to begin a war with the USSR, as it called for an Anglo-American alliance against the Soviets.
== Function == POMC is cut (cleaved) to give rise to multiple peptide hormones. Each of these peptides is packaged in large dense-core vesicles that are released from the cells by exocytosis in response to appropriate stimulation:
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
Mass spectrometry provides the most direct confirmation of molecular mass. Reversed-phase chromatography adds a retention-time signature that supports identity when compared against a reference standard. No single method is sufficient on its own.